Close Asset Management’s Novo Nordisk NVO Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $21K | Hold |
570
| – | – | ﹤0.01% | 204 |
|
|
2025
Q4 | $29K | Sell |
570
-583
| -51% | -$29.8K | ﹤0.01% | 198 |
|
|
2025
Q3 | $64K | Hold |
1,153
| – | – | ﹤0.01% | 161 |
|
|
2025
Q2 | $80K | Sell |
1,153
-783
| -40% | -$53.3K | ﹤0.01% | 154 |
|
|
2025
Q1 | $134K | Buy |
1,936
+1,166
| +151% | +$96.3K | ﹤0.01% | 132 |
|
|
2024
Q4 | $66K | Hold |
770
| – | – | ﹤0.01% | 146 |
|
|
2024
Q3 | $92K | Hold |
770
| – | – | ﹤0.01% | 143 |
|
|
2024
Q2 | $110K | Sell |
770
-1,060
| -58% | -$140K | ﹤0.01% | 136 |
|
|
2024
Q1 | $235K | Sell |
1,830
-30
| -2% | -$3.57K | 0.01% | 115 |
|
|
2023
Q4 | $192K | Sell |
1,860
-60
| -3% | -$5.93K | 0.01% | 118 |
|
|
2023
Q3 | $175K | Sell |
1,920
-40
| -2% | -$3.52K | 0.01% | 112 |
|
|
2023
Q2 | $159K | Sell |
1,960
-160
| -8% | -$13.1K | 0.01% | 118 |
|
|
2023
Q1 | $169K | Sell |
2,120
-440
| -17% | -$31.2K | 0.01% | 104 |
|
|
2022
Q4 | $173K | Sell |
2,560
-700
| -21% | -$41K | 0.01% | 91 |
|
|
2022
Q3 | $162K | Hold |
3,260
| – | – | 0.01% | 90 |
|
|
2022
Q2 | $181K | Sell |
3,260
-540
| -14% | -$30K | 0.01% | 97 |
|
|
2022
Q1 | $213K | Hold |
3,800
| – | – | 0.01% | 89 |
|
|
2021
Q4 | $213K | Hold |
3,800
| – | – | 0.01% | 89 |
|
|
2021
Q3 | $182K | Sell |
3,800
-210
| -5% | -$10.2K | 0.01% | 90 |
|
|
2021
Q2 | $168K | Hold |
4,010
| – | – | 0.01% | 99 |
|
|
2021
Q1 | $135K | Hold |
4,010
| – | – | 0.01% | 108 |
|
|
2020
Q4 | $140K | Hold |
4,010
| – | – | 0.01% | 84 |
|
|
2020
Q3 | $139K | Hold |
4,010
| – | – | 0.01% | 82 |
|
|
2020
Q2 | $131K | Hold |
4,010
| – | – | 0.01% | 85 |
|
|
2020
Q1 | $121K | Hold |
4,010
| – | – | 0.01% | 88 |
|
|
2019
Q4 | $116K | Buy |
4,010
+600
| +18% | +$16.6K | 0.01% | 96 |
|
|
2019
Q3 | $88K | Buy |
3,410
+1,160
| +52% | +$29.3K | 0.01% | 104 |
|
|
2019
Q2 | $57K | Hold |
2,250
| – | – | ﹤0.01% | 117 |
|
|
2019
Q1 | $59K | Buy |
2,250
+1,850
| +463% | +$45.5K | 0.01% | 125 |
|
|
2018
Q4 | $8K | Sell |
400
-1,850
| -82% | -$41.1K | ﹤0.01% | 165 |
|
|
2018
Q3 | $53K | Hold |
2,250
| – | – | ﹤0.01% | 128 |
|
|
2018
Q2 | $54K | Hold |
2,250
| – | – | ﹤0.01% | 124 |
|
|
2018
Q1 | $54K | Hold |
2,250
| – | – | ﹤0.01% | 128 |
|
|
2017
Q4 | $60K | Hold |
2,250
| – | – | 0.01% | 119 |
|
|
2017
Q3 | $54K | Hold |
2,250
| – | – | 0.01% | 122 |
|
|
2017
Q2 | $48K | Hold |
2,250
| – | – | 0.01% | 131 |
|
|
2017
Q1 | $39K | Buy |
2,250
+1,500
| +200% | +$26.1K | ﹤0.01% | 133 |
|
|
2016
Q4 | $13K | Buy |
+750
| New | +$13.6K | ﹤0.01% | 124 |
|
Other funds holding NVO
DAM
F
Close Asset Management's NVO Position: Q1 2026 in Review
Close Asset Management held its Novo Nordisk (NVO) position steady in Q1 2026 at 570 shares worth $21K. The position accounts for ﹤0.01% of the portfolio, ranked #204.
Close Asset Management first reported a position in NVO in Q4 2016 and has held it in 38 quarters since. The position peaked at $235K in Q1 2024. 1,271 funds tracked by Wall St. Rank hold NVO as of Q1 2026.
- Close Asset Management held 570 shares of Novo Nordisk worth $21K as of Q1 2026.
- Close Asset Management left its Novo Nordisk share count unchanged in Q1 2026.
- Novo Nordisk made up ﹤0.01% of Close Asset Management's portfolio in Q1 2026, its #204 holding.
- Close Asset Management first reported a position in Novo Nordisk in Q4 2016 and has held it in 38 quarters since.
- Close Asset Management's Novo Nordisk position peaked at $235K in Q1 2024.
- 1,271 funds tracked by Wall St. Rank held Novo Nordisk as of Q1 2026.
Based on Close Asset Management's 13F filing for Q1 2026, filed 12 May 2026.